Our internationally recognised publications give you access to the expertise of hundreds of the world’s leading scientists, experts and researchers.

Our unrivalled collection of publications spans evidence-based clinical knowledge, research and regulatory information. The extensive breadth of content on MedicinesComplete supports your decision making, from research to the point of care and provides you with the world’s most trusted resources.

We’re excited to announce the launch of two new resources: Martindale’s ADR Checker, a quick and easy tool to support you when managing patients with adverse drug reactions, and the Palliative Care Formulary, the expert source of drug information in palliative and hospice care.

Subscribe Publication Updates

Publication Updates

08 Oct
Dietary Supplements logo
Dietary Supplements October 2019 Update

This update contains revisions to Bee Pollen, Beta Glucan, Betaine, Biotin, Dong Quai, Glucosamine and Greet Tea Extract monographs.

08 Oct
British National Formulary logo
BNF October 2019 Update

This update contains 16 significant changes, 1 dose change and 5 new preparations.

Significant Changes: 

  • Carfilzomib (Kyprolis®): reminder of risk of potentially fatal cardiac events [MHRA/CHM advice].
  • Cemiplimab for treating metastatic or locally advanced cutaneous squamous cell carcinoma [NICE guidance].
  • Dacomitinib for untreated EGFR mutation-positive non-small-cell lung cancer [NICE guidance].
  • Dapagliflozin with insulin for treating type 1 diabetes [NICE guidance].
  • Daratumumab (Darzalex®): risk of reactivation of hepatitis B virus [MHRA/CHM advice].
  • Hyperparathyroidism : New guidance on management of primary hyperparathyroidism.
  • Naltrexone with bupropion (Mysimba®): risk of adverse reactions that could affect ability to drive [MHRA/CHM advice].
  • Olaparib for maintenance treatment of BRCA mutation-positive advanced ovarian, fallopian tube or peritoneal cancer after response to first-line platinum-based chemotherapy [NICE guidance].
  • Patisiran for treating hereditary transthyretin amyloidosis [NICE guidance].
  • Pentosan polysulfate sodium (Elmiron®): risk of pigmentary maculopathy [MHRA/CHM advice].
  • Prostate Cancer : updated guidance on management.
  • Ribociclib with fulvestrant for treating hormone receptor-positive, HER2-negative, advanced breast cancer [NICE guidance].
  • Risankizumab for treating moderate to severe plaque psoriasis [NICE guidance].
  • Rotavirus vaccine : updated guidance in-line with Public Health England recommendations.
  • Ulcerative colitis : updated guidance on management.
  • Vedolizumab for treating moderately to severely active ulcerative colitis [NICE guidance].

Dose Changes:

  • Vitamin B substances with ascorbic acid : Duration and route for the treatment of suspected or established Wernicke’s encephalopathy, and prophylaxis of Wernicke’s encephalopathy updated (BNF only).

New Preparations: Dovato® [ lamivudine with dolutegravir ], Emgality® [ galcanezumab ], Libtayo® [ cemiplimab ], Ondexxya® [ andexanet alfa ], Onpattro® [ patisiran ].

 

For further details on changes in the BNF click on

http://www.medicinescomplete.com/mc/bnf/current/PHP107699-changes.htm

08 Oct
British National Formulary for Children logo
BNFC October 2019 Update

This update contains 3 significant changes.

Significant Changes: 

  • Depression– updated guidance management.
  • Rotavirus vaccine : updated guidance in-line with Public Health England recommendations.
  • Ulcerative colitis : updated guidance on management.

For further details on changes in the BNFC click on https://www.medicinescomplete.com/#/content/bnfc/PHP107699?hspl=changes

 

08 Oct
Stockley's Herbal Medicines Interactions logo
Stockley’s Herbal Medicines Interactions October 2019 Update

Bitter Orange, Green Tea, Hawthorn and Pepper have been selectively revised. Pharmacopoeial information has also been updated. 

Selective Revisions: Bitter Orange, Green Tea, Hawthorn and Pepper.

Minor Updates: USP-NF information globally updated.

08 Oct
AHFS Drug Information logo
AHFS October 2019 Update

This update contains 3 new monographs and 15 revised monographs.

New monographs: Darolutamide; Pexidartinib; Upadacitinib.

Revised monographs: Moxifloxacin; Entacapone; valGANciclovir; Tegaserod; Denosumab; Tofacitinib; Baricitinib; Cemiplimab-rwlc; Baloxavir; Nitroglycerin; Preface to Penicillins; Ganciclovir; Foscarnet; Cidofovir; levoFLOXacin.

08 Oct
Herbal Medicines logo
Herbal Medicines October 2019 Update

Capsicum and Asafoetida have been fully revised. Hibiscus, Liquorice, Nettle and Rhodiola have been selectively revised. Pharmacopoeial, preparations, and manufacturers information have also been updated. 

Revised: Capsicum and Asafoetida.

Selective Revisions: Hibiscus, Liquorice, Nettle and Rhodiola.

Minor Updates: USP-NF information has been globally updated; Appendices, Preparations, and Manufacturers have been updated.

View more